First Drug Designed With Generative AI Enters Phase II Trials
The drug, INS018_055, which was created using generative AI, has been given to patients for the first time in the Phase II clinical trial.
Source: medindia.net
Ins018 055 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ins018 055. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ins018 055 Today - Breaking & Trending Today
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety,
Source: einnews.com